Immediate Impact
1 from Science/Nature 53 standout
Citing Papers
Thirty years of NRF2: advances and therapeutic challenges
2025 Standout
Adipokines: masterminds of metabolic inflammation
2024 Standout
Works of Sandra Thiemann being referenced
Linagliptin monotherapy in type 2 diabetes patients for whom metformin is inappropriate: an 18‐week randomized, double‐blind, placebo‐controlled phase III trial with a 34‐week active‐controlled extension
2012
Author Peers
| Author | Last Decade | Papers | Cites | |||
|---|---|---|---|---|---|---|
| Sandra Thiemann | 392 | 144 | 136 | 16 | 422 | |
| Soichi Nishishita | 256 | 103 | 133 | 11 | 396 | |
| Christina Stahre | 405 | 174 | 151 | 12 | 510 | |
| Yuichi Terawaki | 288 | 232 | 127 | 13 | 406 | |
| Mario Maldonado | 291 | 111 | 100 | 16 | 404 | |
| Irene Caruso | 338 | 172 | 117 | 27 | 480 | |
| Burkhard Goeke | 393 | 143 | 198 | 13 | 498 | |
| Yasutaka Takeda | 228 | 170 | 179 | 20 | 444 | |
| F. Ravandi Kashani | 221 | 160 | 127 | 17 | 482 | |
| Michael E. Cobble | 304 | 122 | 142 | 17 | 487 | |
| Sudipta Bhattacharya | 385 | 165 | 128 | 12 | 458 |
All Works
Loading papers...